These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10731264)

  • 1. Successful non-operative management of right coronary artery perforation during percutaneous coronary intervention in a patient receiving abciximab and aspirin.
    Del Campo C; Zelman R
    J Invasive Cardiol; 2000 Jan; 12(1):41-3. PubMed ID: 10731264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary artery perforation in patients undergoing percutaneous coronary intervention: a single-centre report.
    Georgiadou P; Karavolias G; Sbarouni E; Adamopoulos S; Malakos J; Voudris V
    Acute Card Care; 2009; 11(4):216-21. PubMed ID: 19742353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary percutaneous coronary intervention complicated by left anterior descending artery perforation - a case report].
    Debiński M; Zurakowski A; Buszman P
    Kardiol Pol; 2009 Apr; 67(4):446-8; discussion 449-50. PubMed ID: 19492262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first".
    Kereiakes DJ; Fry E; Matthai W; Niederman A; Barr L; Brodie B; Zidar J; Casale P; Christy G; Moliterno D; Lengerich R; Broderick T; Shimshak T; Cohen M
    J Invasive Cardiol; 2000 Feb; 12 Suppl A():1A-5A. PubMed ID: 10731289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting.
    Bagur R; Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Nguyen CM; Noel B; Larochellière RD; Poirier P; Costerousse O; Roy L
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1010-6. PubMed ID: 19753635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful collapse vessel treatment with a syringe for thrombus-aspiration after the guidewire-induced coronary artery perforation.
    Yasuoka Y; Sasaki T
    Cardiovasc Revasc Med; 2010; 11(4):263.e1-3. PubMed ID: 20934662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Do low risk patients undergoing percutaneous coronary intervention after pretreatment with clopidogrel need abciximab infusion? Results of ISAR-REACT study].
    Gratsianskiĭ NA
    Kardiologiia; 2004; 44(3):80-1. PubMed ID: 15489837
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.
    Hausleiter J; Kastrati A; Mehilli J; Schühlen H; Pache J; Dotzer F; Glatthor C; Siebert S; Dirschinger J; Schömig A;
    J Intern Med; 2004 Nov; 256(5):388-97. PubMed ID: 15485474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
    Zahn R; Haubelt H; Bechtloff S; Schneider S; Frilling B; Rustige J; Marsalek P; Seidl K; Senges J; Hellstern P
    Herz; 2003 Aug; 28(5):445-52. PubMed ID: 12928744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing pattern of coronary perforation during percutaneous coronary intervention in the new device era.
    Witzke CF; Martin-Herrero F; Clarke SC; Pomerantzev E; Palacios IF
    J Invasive Cardiol; 2004 Jun; 16(6):257-301. PubMed ID: 15155997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.
    Lenderink T; Boersma E; Ruzyllo W; Widimsky P; Ohman EM; Armstrong PW; Wallentin L; Simoons ML;
    Am Heart J; 2004 May; 147(5):865-73. PubMed ID: 15131544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing and administration of ReoPro (c7E3 Fab).
    Tcheng JE
    J Invasive Cardiol; 1994; 6 Suppl A():29A-33A; discussion 51A-54A. PubMed ID: 10155091
    [No Abstract]   [Full Text] [Related]  

  • 14. Microcoil embolization of distal coronary artery perforation without reversal of anticoagulation: a simple, effective approach.
    Ponnuthurai FA; Ormerod OJ; Forfar C
    J Invasive Cardiol; 2007 Aug; 19(8):E222-5. PubMed ID: 17712210
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe left atrium compression after percutaneous coronary intervention with perforation of a circumflex branch of the left coronary artery.
    Krabatsch T; Becher D; Schweiger M; Hetzer R
    Interact Cardiovasc Thorac Surg; 2010 Dec; 11(6):811-3. PubMed ID: 20739408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention.
    Kereiakes DJ; Grines C; Fry E; Esente P; Hoppensteadt D; Midei M; Barr L; Matthai W; Todd M; Broderick T; Rubinstein R; Fareed J; Santoian E; Neiderman A; Brodie B; Zidar J; Ferguson JJ; Cohen M;
    J Invasive Cardiol; 2001 Apr; 13(4):272-8. PubMed ID: 11287711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results.
    Popma JJ; Satler LF
    J Invasive Cardiol; 1994; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel.
    Schömig A; Schmitt C; Dibra A; Mehilli J; Volmer C; Schühlen H; Dirschinger J; Dotzer F; ten Berg JM; Neumann FJ; Berger PB; Kastrati A;
    Eur Heart J; 2005 Jul; 26(14):1379-84. PubMed ID: 15734767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intracoronary compared to intravenous abciximab administration in patients undergoing transradial percutaneous coronary intervention: A sub-analysis of the EASY trial.
    Bertrand OF; Rodés-Cabau J; Larose E; Nguyen CM; Déry JP; Proulx G; Roy L; Poirier P; Costerousse O; De Larochellière R
    Int J Cardiol; 2009 Aug; 136(2):165-70. PubMed ID: 18656274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary administration of abciximab during percutaneous coronary interventions: should this be the routine and preferred approach?
    Sharma S; Makkar R; Lardizabal J
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):136-41. PubMed ID: 16891291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.